Abstract
Kir2.1, a strong inward rectifier potassium channel encoded by the KCNJ2 gene, is a key regulator of the resting membrane potential of the cardiomyocyte and plays an important role in controlling ventricular excitation and action potential duration in the human heart. Mutations in KCNJ2 result in inheritable cardiac diseases in humans, e.g. the type-1 Andersen-Tawil syndrome (ATS1). Understanding the molecular mechanisms that govern the regulation of inward rectifier potassium currents by Kir2.1 in both normal and disease contexts should help uncover novel targets for therapeutic intervention in ATS1 and other Kir2.1-associated channelopathies. The information available to date on protein-protein interactions involving Kir2.1 channels remains limited. Additional efforts are necessary to provide a comprehensive map of the Kir2.1 interactome. Here we describe the generation of a comprehensive map of the Kir2.1 interactome using the proximity-labeling approach BioID. Most of the 218 high-confidence Kir2.1 channel interactions we identified are novel and encompass various molecular mechanisms of Kir2.1 function, ranging from intracellular trafficking to cross-talk with the insulin-like growth factor receptor signaling pathway, as well as lysosomal degradation. Our map also explores the variations in the interactome profiles of Kir2.1WTversus Kir2.1Δ314-315, a trafficking deficient ATS1 mutant, thus uncovering molecular mechanisms whose malfunctions may underlie ATS1 disease. Finally, using patch-clamp analysis, we validate the functional relevance of PKP4, one of our top BioID interactors, to the modulation of Kir2.1-controlled inward rectifier potassium currents. Our results validate the power of our BioID approach in identifying functionally relevant Kir2.1 interactors and underline the value of our Kir2.1 interactome as a repository for numerous novel biological hypotheses on Kir2.1 and Kir2.1-associated diseases.
Highlights
Generation using BioID of a map of the Kir2.1 interactome with 218 interactions
Understanding the molecular mechanisms that govern the regulation of inward rectifier potassium currents by Kir2.1 in both normal and disease contexts should help uncover novel targets for therapeutic intervention in type-1 Andersen-Tawil syndrome (ATS1) and other Kir2.1-associated channelopathies
Leonoudakis et al showed that the PDZ-binding motif of Kir2.1 interacts with the SAP97, CASK and LIN7C proteins, members of the membrane-associated guanylate kinase (MAGUK) family, which work both as scaffolding proteins for large
Summary
Generation using BioID of a map of the Kir2.1 interactome with 218 interactions. Identification of Kir2.1WT- versus Kir2.1D314-315-preferred interactors. The strong inward rectifier potassium channel Kir2.1 is a key regulator of the resting membrane potential of the cardiomyocyte and plays an important role in controlling ventricular excitation and action potential duration in the human heart [1,2,3] Both loss and gain of function mutations in KCNJ2, the gene encoding Kir2.1, result in inheritable cardiac ion channel diseases. Beyond interactome mapping, our BioID experiments aim to capture the differences between the protein interaction profiles of Kir2.1WT versus Kir2.1D314-315 proteins, and to uncover the molecular mechanisms whose malfunctions underlie ATS1 disease. We present patch-clamp analyses of one of our top BioID interactors, PKP4, which validate its functional relevance to modulation of Kir2.1-regulated inward rectifier potassium currents
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.